BCL2 and cancer: Differently from bcl-2 family molecules, IAP proteins are thought to block a highly evolutionarily conserved step in cell death by binding and inhibiting terminal effector caspases-3 and –7 (Deveraux et al, 1998), thus providing a separate and nonredundant pathway of cell viability in cancer.